• Financials
• Stock Watch
• Earnings Estimate
• Fundamentals
• Trading Statistics *
• Ratios *
• Balance Sheet Highlights *
• Cash Flow Highlights *
• Income Statement Highlights *
• Shareholder Reports
• Webcasts
• Regulatory Filings
• Product Pipeline
• About Biovail
• The Company
• Business Strategy
• Affiliated Companies
• Corporate Governance
• Press Room
• Contact Us
• Investor Contact
• Analysts
• Request Investor Information
• Corporate Fact Sheet

TORONTO--(BUSINESS WIRE)--May. 11, 2009-- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company will participate at the Bank of America and Merrill Lynch 2009 Health Care Conference at the Palace Hotel in New York City and at the Deutsche Bank 2009 Annual Health Care Conference at the InterContinental Boston Hotel.

Biovail’s Bank of America and Merrill Lynch conference presentation is scheduled for Tuesday, May 12, 2009 at 8a.m. EST. The Deutsche Bank conference presentation is scheduled for Tuesday, May 19, 2009 at 8:50a.m. EST. A live and archived Webcast will be available on the Investor Relations page of Biovail’s Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.

Source: Biovail Corporation

Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice President, Investor Relations &
Corporate Communications